Visual prognostic factors following surgery for stage 3 idiopathic epiretinal membrane by Govetto classification
Japanese Journal of Ophthalmology · 2024
DOI: 10.1007/s10384-024-01110-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Ophthalmology, 2024. Verfasst von Takafumi Suzuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shinseikai Toyama Hospital, 89-10 Shimowaka, Imizu-shi, Toyama, 939-0243, Japan. etoile1914100@gmail.com. Hauptthemen laut MEDLINE: Epiretinal Membrane, Tomography, Optical Coherence, Visual Acuity, Vitrectomy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To investigate the visual prognosis of metamorphopsia in patients undergoing surgery for stage 3 idiopathic epiretinal membrane (ERM) by Govetto classification using preoperative optical coherence tomography (OCT) parameters. STUDY DESIGN: Retrospective clinical study. METHOD: This study included 45 eyes of 45 patients with a minimum follow-up period of 3 months. The best-corrected visual acuity (BCVA) and metamorphopsia score using the M-CHARTS were recorded. Central foveal thickness (CFT), inner nuclear layer thickness (INL), ectopic inner retinal layer thickness (EIFL), outer retinal layer thickness, disruption of the ellipsoid zone, cotton ball sign, and intraretinal cystoid changes were measured based on spectral domain OCT. Preoperative and postoperative values and conditions were compared, and correlations between the preoperative values or conditions and postoperative metamorphopsia scores or BCVA were analyzed. RESULTS: After surgery, the horizontal, vertical, and mean metamorphopsia scores, as well as BCVA, CFT, INL, and EIFL significantly improved (p < 0.001). Using multivariate analysis, only preoperative CFT was a significant explanatory parameter for both the postoperative horizontal metamorphopsia scores and mean values of the postoperative horizontal and vertical metamorphopsia scores (p = 0.019 and p = 0.011, respectively). Age (p = 0.011) and preoperative CFT (p = 0.026) were significant explanatory parameters of postoperative BCVA. CONCLUSION: Preoperative CFT significantly correlated with postoperative metamorphopsia in patients undergoing surgery for stage 3 idiopathic ERM. This finding might help surgeons predict postoperative visual outcomes and make timely surgical decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Shinseikai Toyama Hospital, 89-10 Shimowaka, Imizu-shi, Toyama, 939-0243, Japan. etoile1914100@gmail.com.
- Department of Ophthalmology, University of Tokyo Hospital, 7-3-1 Hongō, Bunkyō-ku, Tokyo, 113-8655, Japan. etoile1914100@gmail.com.
- Department of Ophthalmology, Shinseikai Toyama Hospital, 89-10 Shimowaka, Imizu-shi, Toyama, 939-0243, Japan.
- Tachi Eye Clinic, 1-2-3 Shintomi-cho, Toyama-shi, Toyama, 930-0002, Japan.
- Department of Ophthalmology, University of Tokyo Hospital, 7-3-1 Hongō, Bunkyō-ku, Tokyo, 113-8655, Japan.
Zitieren
APA
Suzuki, T., Otaki, C., Ueta, Y., Tate, H., Tachi, N., Nagahara, M., Azuma, K., Ueta, T., & Aihara, M. (2024). Visual prognostic factors following surgery for stage 3 idiopathic epiretinal membrane by Govetto classification. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-024-01110-1
Vancouver
Suzuki T, Otaki C, Ueta Y, Tate H, Tachi N, Nagahara M, et al. Visual prognostic factors following surgery for stage 3 idiopathic epiretinal membrane by Govetto classification. Japanese Journal of Ophthalmology. 2024. doi:10.1007/s10384-024-01110-1
BibTeX
@article{Suzuki2024,
author = {Suzuki, Takafumi and Otaki, Chisato and Ueta, Yoshiki and Tate, Hideo and Tachi, Naoko and Nagahara, Masako and Azuma, Kunihiro and Ueta, Takashi and Aihara, Makoto},
title = {Visual prognostic factors following surgery for stage 3 idiopathic epiretinal membrane by Govetto classification},
journal = {Japanese Journal of Ophthalmology},
year = {2024},
doi = {10.1007/s10384-024-01110-1}
}
EUVIMED